Detailed answers about THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD, including incorporation, status, business activity, and accounts information.
When was THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD founded?
THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD was officially incorporated on 21 November 2024 and is registered under company number 16092679. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD?
THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD do?
THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD operates in the following sector: 41201 - Construction of commercial buildings. This provides insight into the company's primary business activity and industry focus.
What is THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD's registered address?
The registered office address of THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD is BHF PRIORY CENTRE, PONTEFRACT ROAD, BARNSLEY, UNITED KINGDOM, S71 5PN. This is the official address filed with Companies House for legal and statutory correspondence.
Is THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD financially stable?
Financial accounts for THE BARNSLEY HEALTH AND PHARMA COLLABORATIVE LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.